Your browser doesn't support javascript.
loading
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Joly, F; Ahmed-Lecheheb, D; Kalbacher, E; Heutte, N; Clarisse, B; Grellard, J M; Gernier, F; Berton-Rigaud, D; Tredan, O; Fabbro, M; Savoye, A M; Kurtz, J E; Alexandre, J; Follana, P; Delecroix, V; Dohollou, N; Roemer-Becuwe, C; De Rauglaudre, G; Lortholary, A; Prulhiere, K; Lesoin, A; Zannetti, A; N'Guyen, S; Trager-Maury, S; Chauvenet, L; Abadie Lacourtoisie, S; Gompel, A; Lhommé, C; Floquet, A; Pautier, P.
Afiliação
  • Joly F; Department of Oncology, Centre François Baclesse, Caen; INSERM, U1086, Caen; UMR-S1077, University of Caen Basse-Normandie, Caen; Department of Oncology, CHU de Caen, Caen. Electronic address: f.joly@baclesse.unicancer.fr.
  • Ahmed-Lecheheb D; Department of Oncology, Centre François Baclesse, Caen; INSERM, U1086, Caen.
  • Kalbacher E; Department of Oncology, CHU Jean Minjoz, Besançon.
  • Heutte N; Department of Clinical Research, Centre François Baclesse, Caen.
  • Clarisse B; Department of Clinical Research, Centre François Baclesse, Caen.
  • Grellard JM; Department of Clinical Research, Centre François Baclesse, Caen.
  • Gernier F; INSERM, U1086, Caen; Department of Clinical Research, Centre François Baclesse, Caen.
  • Berton-Rigaud D; Department of Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Saint Herblain.
  • Tredan O; Department of Oncology, Centre Léon Bérard, Lyon.
  • Fabbro M; Department of Oncology, Institut Régional du Cancer, Montpellier.
  • Savoye AM; Department of Oncology, Institut Jean Godinot, Reims.
  • Kurtz JE; Department of Oncology, Hôpitaux Universitaires de Strasbourg, Strasbourg.
  • Alexandre J; Department of Oncology, Hôpital Cochin, Paris.
  • Follana P; Department of Oncology, Centre Antoine Lacassagne, Nice.
  • Delecroix V; Department of Oncology, Clinique Mutualiste de l'Estuaire, Saint-Nazaire.
  • Dohollou N; Department of Oncology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux.
  • Roemer-Becuwe C; Department of Oncology, Centre d'Oncologie de Gentilly, Nancy.
  • De Rauglaudre G; Department of Oncology, Institut Sainte Catherine, Avignon.
  • Lortholary A; Department of Oncology, Centre Catherine de Sienne, Nantes.
  • Prulhiere K; Department of Oncology, Institut du Cancer Courlancy, Reims.
  • Lesoin A; Department of Oncology, Centre Oscar Lambret, Lille.
  • Zannetti A; Department of Oncology, Centre Hospitalier de Cholet, Cholet.
  • N'Guyen S; Department of Oncology, CH Pau, Pau.
  • Trager-Maury S; Department of Oncology, GHPSO Senlis, Senlis.
  • Chauvenet L; Department of Oncology, Centre Hospitalier de Sens, Sens.
  • Abadie Lacourtoisie S; Department of Oncology, Institut de Cancérologie de l'Ouest, Site Paul Papin, Angers.
  • Gompel A; Department of Oncology, Hôpitaux Universitaires Cochin Hôtel-Dieu Broca, Paris.
  • Lhommé C; Department of Oncology, Gustave Roussy, Villejuif.
  • Floquet A; Department of Oncology, Institut Bergonié, Bordeaux, France.
  • Pautier P; Department of Oncology, Gustave Roussy, Villejuif.
Ann Oncol ; 30(5): 845-852, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30851097
ABSTRACT

BACKGROUND:

Few data are available on long-term fatigue (LTF) and quality of life (QoL) among epithelial ovarian cancer survivors (EOCS). In this case-control study, we compared LTF, symptoms and several QoL domains in EOCS relapse-free ≥3 years after first-line treatment and age-matched healthy women. PATIENTS AND

METHODS:

EOCS were recruited from 25 cooperative GINECO centers in France. Controls were randomly selected from the electoral rolls. All participants completed validated self-reported questionnaires fatigue (FACIT-F), QoL (FACT-G/O), neurotoxicity (FACT-Ntx), anxiety/depression (HADS), sleep disturbance (ISI), and physical activity (IPAQ). Severe LTF (SLTF) was defined as a FACIT-F score <37/52. Univariate and multivariate logistic regressions were conducted to analyze SLTF and its influencing factors in EOCS.

RESULTS:

A total of 318 EOCS and 318 controls were included. EOCS were 63-year-old on average, with FIGO stage I/II (50%), III/IV (48%); 99% had received platinum and taxane chemotherapy, with an average 6-year follow-up. There were no differences between the two groups in socio-demographic characteristics and global QoL. EOCS had poorer FACIT-F scores (40 versus 45, P < 0.0001), lower functional well-being scores (18 versus 20, P = 0.0002), poorer FACT-O scores (31 versus 34 P < 0.0001), and poorer FACT-Ntx scores (35 versus 39, P < 0.0001). They also reported more SLTF (26% versus 13%, P = 0.0004), poorer sleep quality (63% versus 47%, P = 0.0003), and more depression (22% versus 13%, P = 0.01). Fewer than 20% of EOCS and controls exercised regularly. In multivariate analyses, EOCS with high levels of depression, neurotoxicity, and sleep disturbance had an increased risk of developing SLTF (P < 0.01).

CONCLUSION:

Compared with controls, EOCS presented similar QoL but persistent LTF, EOC-related symptoms, neurotoxicity, depression, and sleep disturbance. Depression, neuropathy, and sleep disturbance are the main conditions associated with severe LTF.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Qualidade de Vida / Fadiga / Sobreviventes de Câncer / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Qualidade de Vida / Fadiga / Sobreviventes de Câncer / Carcinoma Epitelial do Ovário Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article